Annual Report

Overview

The report presents FY 2019-20 performance under the "Hope Wins. Life Wins." theme, including consolidated revenue of INR 3,325 crore and a strategic divestment of part of the domestic branded business. It highlights the R&D pipeline, including six antibiotics with QIDP status and approvals for two new antibiotics in India. Its CSR initiatives report more than 117.87 million lives touched through healthcare, education, sanitation and other programmes.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Publication date: 11 May 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services